Revenues grew 13% YoY to | 1896 crore (I-direct estimate: | 1869 crore) on the back of 13% YoY increase in healthcare business to | 1008 crore (I-direct estimate: | 1009 crore) and 13% YoY increase in pharmacy business to | 888 crore (I-direct estimate: | 860 crore) EBITDA margins improved a mere 12 bps YoY to 11.7% (I-direct estimate: 12.5%). Higher gross margins were largely offset by higher employee cost and other expenditure. EBITDA increased 14% YoY at | 221 crore (I-direct estimate: | 234 crore)...